Sendai virus has various natural advantages, including non-integrability, extremely high production titer, extremely high transgenic expression performance, significant target cell breadth, and no potential pathogenicity to humans.
We are committed to promoting our unique research and development of recombinant Sendai virus vector technology to the world, including virus transformation into different types of products, and providing customized carrier packaging services for scientific research institutions and biopharmaceutical enterprises.